Digital technologies have the potential to play a crucial role in combating this pressing global health issue. This Series in The Lancet Digital Health features three papers discussing the latest ...
The G20 Leaders’ Summit in Rio de Janeiro on Nov 18–19 will address global health, but uncertainty over multilateralism under a new US President looms large. John Zarocostas reports.
Every year more than 10 million people die unnecessarily from consuming tobacco, alcohol, and sugary beverages.1 In the wake of the COVID-19 pandemic and other crises constraining fiscal space, ...
The world's first self-amplifying mRNA vaccine, or replicon vaccine, was administered in Japan to prevent SARS-CoV-2 infection.1 Similar to other infodemics related to COVID-19 vaccines,2 ...
In relation to the Review on hypopituitarism by Maria Fleseriu and colleagues,1 we would like to raise awareness about Nakalanga syndrome, a poorly understood condition most likely caused by ...
Donald Trump's decisive re-election as US President on Nov 5 puts many aspects of health and science in a deeply concerning position. Although there is broader alarm about his openly authoritarian ...
We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...